Screening of commercial cyclic peptide conjugated to HIV-1 Tat peptide as inhibitor of N-terminal heptad repeat glycoprotein-2 ectodomain Ebola virus through in silico analysis
Research output: Contribution to journal › Article › peer-review
21Citations
(Scopus)
Fingerprint
Dive into the research topics of 'Screening of commercial cyclic peptide conjugated to HIV-1 Tat peptide as inhibitor of N-terminal heptad repeat glycoprotein-2 ectodomain Ebola virus through in silico analysis'. Together they form a unique fingerprint.